Vicki Huff

Overview

Best Publications

• Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

  Paul E. Grundy;Norman E. Breslow;Sierra Li;Elizabeth Penman

  520
  Citations

• Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome

  Paul E. Grundy;Perry E. Telzerow;Norman Breslow;Jamie Moksness

  359
  Citations

• A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.

  Samantha Gadd;Vicki Huff;Amy L. Walz;Ariadne H.A.G. Ooms

  327
  Citations

• Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors

  Amy L. Walz;Ariadne Ooms;Samantha Gadd;Daniela S. Gerhard

  289
  Citations

• The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis.

  Fei Gao;Sourindra Maiti;Nargis Alam;Zhen Zhang

  276
  Citations

• Lack of linkage of familial Wilms' tumour to chromosomal band 11 p13

  Vicki Huff;Duane A. Compton;Lian Yu Chao;Louise C. Strong

  266
  Citations

• Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

  E. Cristy Ruteshouser;Stephen M. Robinson;Vicki D Huff

  256
  Citations

• Frequent Association of β-Catenin and WT1 Mutations in Wilms Tumors

  Sourindra Maiti;Rita Alam;Christopher I. Amos;Vicki Huff

  253
  Citations

• Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT.

  Vicki Huff;Hiroshi Miwa;Daniel A. Haber;Katherine M. Call

  226
  Citations

• Wt1 negatively regulates Β-catenin signaling during testis development

  Hao Chang;Fei Gao;Florian Guillou;Makoto M. Taketo

  220
  Citations

• Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development.

  Brigitte Royer-Pokora;Manfred Beier;Markus Henzler;Rita Alam

  203
  Citations

• Treatment With Nephrectomy Only for Small, Stage I/Favorable Histology Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

  D. M. Green;N. E. Breslow;J. B. Beckwith;M. L. Ritchey

  196
  Citations

• Children's Oncology Group's 2013 blueprint for research: Renal tumors

  Jeffrey S. Dome;Conrad V. Fernandez;Elizabeth A. Mullen;John A. Kalapurakal

  179
  Citations

• Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.

  Marcio Malogolowkin;Cecilia A. Cotton;Cecilia A. Cotton;Daniel M. Green;Daniel M. Green;Norman E. Breslow;Norman E. Breslow

  178
  Citations

• Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models

  Silvestre Vicent;Ron Chen;Leanne C. Sayles;Chenwei Lin

  163
  Citations

• The Wilms tumor gene, Wt1, is critical for mouse spermatogenesis via regulation of sertoli cell polarity and is associated with non-obstructive azoospermia in humans.

  Xiao Na Wang;Ze Song Li;Ze Song Li;Yu Ren;Tao Jiang

  158
  Citations

• Linkage of Familial Wilms' Tumor Predisposition to Chromosome 19 and a Two-Locus Model for the Etiology of Familial Tumors

  J. Matthew McDonald;Edwin C. Douglass;Ross Fisher;Clementina F. Geiser

  151
  Citations

• Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.

  Max J. Coppes;Vicki D Huff;Jerry Pelletier

  141
  Citations

• Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

  Qianghua Hu;Fei Gao;Weihua Tian;E. Cristy Ruteshouser

  132
  Citations

• Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.

  Daniel M. Green;Daniel M. Green;Cecilia A. Cotton;Marcio Malogolowkin;Norman E. Breslow

  125
  Citations